Search Results

You searched for : Eisai  

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment Responses

As the field continues to advance, integrating genetic information into treatment strategies will be essential for improving outcomes and developing targeted therapies for Alzheimer’s ...
May 08

AbbVie, Eisai, and EA Pharma launch “Humira support tool ordering service for Patients”

Latest pharma news update...
Sep 16

Eisai and Biogen Inc. get U.S. FDA grants breakthrough therapy designation for Lecanemab (BAN2401)

Lecanemab is indicated for the treatment of Alzheimer’s Disease...
Jun 26

Eisai and Bristol Myers Squibb enter Into strategic Collaboration for Eisai’s MORAb-202 Antibody drug conjugate

The companies are planning to move into the registrational stage of development for this asset as early as next year....
Jun 21

Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai’s MORAb-202 Antibody Drug Conjugate

...
Jun 18

Gilead and Galapagos announce new commercialization and development agreement for Jyseleca

Gilead and Galapagos will continue to investigate the potential for filgotinib to support patients living with Inflammatory Bowel Disease...
Dec 16

KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival

...
Dec 16

Biogen Files New Drug Application for Aducanumab in Japan

Today, Biogen and Eisai, Co., Ltd. announced that Biogen has submitted a Japanese New Drug Application (J-NDA) to the Ministry of Health, Labor and ...
Dec 10

Technology - an integral part of medicine says Dr. Shubham Painoli, Quality Manager – Clinical Operations, DayToDay Health

...
Dec 09

Eisai receives approval for indication expansion of anti-epileptic agent fycompa for use in pediatric patients

...
Dec 01

Eisai collaborates with Wren Therapeutics for drug discovery for Synucleinopathies

The collaboration will use Wren's network kinetics drug discovery platform, alongside Eisai's extensive experience in drug discovery for neurodegenerative disorders...
Nov 30

Eisai receives approval for indication expansion of anti-epileptic agent fycompa for use in pediatric patients

The approval was based on the results of Phase III and Phase II clinical studies conducted globally to evaluate Fycompa as an adjunctive therapy in ...
Nov 16

KEYTRUDA plus LENVIMA met the trial’s primary endpoint of progression-free survival

LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma...
Nov 10

FDA advisory panel not convinced of experimental Alzheimer's drug's effectiveness

Public Citizen's Health Research Group said that the FDA should not approve aducanumab for treatment of Alzheimer's disease due to lack of evidence ...
Nov 07

Eisai associated with four research organizations in Japan for development of therapeutics for novel COVID-19

This collaborative research, aims to elucidate the mechanism of COVID-19 aggravation based on SARS-CoV-2 infection and to create drugs that prevent the ...
Oct 08

Biogen applies for FDA approval of Aducanumab for Alzheimer's disease

The FDA now has up to 60 days to decide whether to accept the application for review...
Jul 09

Eisai Submits Marketing Authorization Application in Japan for Anticancer Agent Denileukin Diftitox (Genetic Recombinant)

For Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma...
Mar 30

The 13th Edition of CPhI & P-MEC India Expo Leads the Transformation in the Global Pharmaceutical Space

A new chapter of the widely appreciated India Pharma Week by Informa Markets in India concurrently began at the India Expo Centre, Greater Noida...
Nov 27

18 Matching result(s) found!

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026